Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-74.99%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 5.93Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -102.94M | -74.99% | $ 137.27M |
| 3/31/2025 | $ -122.75M | -86.36% | $ 142.13M |
| 12/31/2024 | $ -127.49M | -87.78% | $ 145.24M |
| 9/30/2024 | $ -120.26M | -81.02% | $ 148.44M |
| 6/30/2024 | $ -130.34M | -89.48% | $ 145.67M |
| 3/31/2024 | $ -117.54M | -83.68% | $ 140.46M |
| 12/31/2023 | $ -92.72M | -63.49% | $ 146.03M |
| 9/30/2023 | $ -100.98M | -69.23% | $ 145.87M |
| 6/30/2023 | $ -99.82M | -68.37% | $ 146M |
| 3/31/2023 | $ -109.27M | -73.78% | $ 148.1M |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -185.65%.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average OCF % has been -92.41%.
- The median OCF % for KARYOPHARM THERAPEUTICS INC during this period was -82.35%
- KARYOPHARM THERAPEUTICS INC reached its highest OCF % over the past 5 years at -36.94%.
- The lowest OCF % recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe -185.65%
KARYOPHARM THERAPEUTICS INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for KARYOPHARM THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -169.09M ] / Revenues [ $ 91.08M ]
(=) OCF % [ -185.65% ] KPTI - Operating Cash Flow Margin, Last 5 years
-185.65%
Minimum
Sep 30, 2020
-36.94%
Maximum
Jun 30, 2022
-92.41%
Average
-82.35%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |